Question 1

How big the rare disease treatment industry?

Accepted Answer

Rare disease treatment market size was USD 205.3 billion in 2023 and is expected to register over 9% CAGR from 2024-2032 owing to the increasing prevalence of cancer and other rare diseases across the globe.

Question 2

Who are the key leaders in the rare disease treatment industry?

Accepted Answer

Bayer AG, Biogen, GSK plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Novo Nordisk, Pfizer, Inc., Pharmacyclics LLC, Sanofi SA, Seagen Inc., Takeda Pharmaceutical Company Limited., and Vertex Pharmaceutical, Inc., are some of the major rare disease treatment companies worldwide.

Question 3

What is the size of the North America rare disease treatment market?

Accepted Answer

North America rare disease treatment industry held 48.8% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to an increase in the number of rare diseases, and rising awareness regarding the benefits of precision medicine in the region.

Question 4

Why is the use of biologics for rare disease treatment growing?

Accepted Answer

Rare disease treatment industry from the biologics segment reached USD 166.9 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to its several benefits, such as, high specificity, low toxicity, extreme sensitivity to physical conditions, etc.

Rare Disease Treatment Market Share

Rare Disease Treatment Market Share

Rare Disease Treatment Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters